Dai Hashimoto
Overview
Explore the profile of Dai Hashimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kono M, Enomoto N, Inoue Y, Yasui H, Karayama M, Suzuki Y, et al.
Respir Investig
. 2025 Feb;
63(2):216-223.
PMID: 39892159
Background: Idiopathic interstitial pneumonias (IIPs) may remain unclassifiable owing to inadequate, nonspecific, or conflicting clinical, radiological, or histopathological findings despite multidisciplinary discussion (MDD). Unclassifiable IIP (UCIIP) is a heterogeneous disease...
2.
Yasui H, Oishi K, Nihashi F, Furuhashi K, Fujisawa T, Inoue Y, et al.
Respir Med
. 2024 Nov;
236():107881.
PMID: 39580034
Background: Despite the development of biologics for severe asthma, individuals with uncontrolled status persist, posing a significant social problem. This multicenter prospective study aimed to identify factors associated with the...
3.
Karayama M, Inui N, Inoue Y, Yasui H, Hozumi H, Suzuki Y, et al.
BMC Pulm Med
. 2024 Oct;
24(1):495.
PMID: 39379903
Background: Immune-related pneumonitis (irP) is one of the most important immune-related adverse events caused by immune checkpoint inhibitors (ICIs). After corticosteroid therapy irP frequently relapses, which can interfere with cancer...
4.
3D-CT-derived lung volumes and mortality risk in patients with fibrotic hypersensitivity pneumonitis
Yazawa S, Suzuki Y, Tanaka Y, Yokomura K, Kono M, Hashimoto D, et al.
Allergol Int
. 2024 Sep;
74(1):78-85.
PMID: 39242341
Background: Hypersensitivity pneumonitis (HP) is a complex and heterogenous interstitial lung disease (ILD) that occurs in susceptible individuals due to certain inhaled antigens. Fibrotic-HP is a major underlying disease of...
5.
Kono M, Saito T, Tsunoda T, Ikeda S, Arano T, Watanuki M, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2024 Jun;
41(2):e2024026.
PMID: 38940713
Background And Aim: Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare form of idiopathic interstitial pneumonias; its physical characteristics include a slender build with platythorax and progressive weight loss. However, the...
6.
Inui N, Suzuki T, Tanaka K, Karayama M, Inoue Y, Mori K, et al.
J Clin Oncol
. 2024 Jun;
42(23):2780-2789.
PMID: 38833659
Purpose: We evaluated the efficacy and safety of antiemetic therapy with olanzapine, a neurokinin-1 receptor antagonist (RA), a 5-hydroxytryptamine-3 (5-HT) RA, and dexamethasone for preventing chemotherapy-induced nausea and vomiting in...
7.
Takuma S, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, et al.
Respir Med
. 2024 Feb;
223:107542.
PMID: 38331228
Background: Antifibrotic therapy is widely used for patients with progressive fibrotic interstitial lung disease (ILD), regardless of etiology. There is an urgent need for a simple, inexpensive, and repeatable biomarker...
8.
Fukada A, Fujisawa T, Hozumi H, Koda K, Akamatsu T, Oyama Y, et al.
Arthritis Rheumatol
. 2023 Dec;
76(5):796-805.
PMID: 38146102
Objective: Interferon-λ3 (IFNλ3) is a cytokine with antiviral functions on barrier surfaces, and it is associated with disease activity in autoimmune diseases. This study assessed the clinical significance of serum...
9.
Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Imokawa S, et al.
BMJ Open Respir Res
. 2023 Dec;
10(1).
PMID: 38081767
Background: Idiopathic pleuroparenchymal fibroelastosis (iPPFE), a progressive fibrotic disease, is characterised by upper lobe-dominant lung fibrosis involving the pleura and subpleural lung parenchyma. However, no prognostic markers have been established...
10.
Suzuki T, Karayama M, Aoshima Y, Mori K, Yoshizawa N, Ichikawa S, et al.
Respirology
. 2023 Nov;
29(2):136-145.
PMID: 37921012
Background And Objective: The lung immune prognostic index (LIPI), a simple index calculated from the blood lactate dehydrogenase level and derived neutrophil-to-lymphocyte ratio, is thought to be associated with host...